Liver, gallbladder, extrahepatic bile ducts, and pancreas
- PMID: 8000995
- DOI: 10.1002/1097-0142(19950101)75:1+<171::aid-cncr2820751306>3.0.co;2-2
Liver, gallbladder, extrahepatic bile ducts, and pancreas
Abstract
Background: The liver, gallbladder, bile ducts, and pancreas have a common embryologic origin; cancers that arise from these sites therefore are expected to share a similar spectrum of histologic types. These cancers are known for their extremely poor prognoses.
Methods: Data from the Surveillance, Epidemiology, and End Results Program regarding the incidence, distribution of histologic types, stage of disease, and survival for cancers of the gallbladder (n = 4412), extrahepatic bile ducts (n = 3486), pancreas (n = 23,116), and liver (n = 6,391) were reviewed. The most common histologic types are discussed, and the frequency of rare types is reported.
Results: The incidence of biliary cancer decreased, while the incidence of hepatic and pancreatic cancer rose slightly over the 15-year period from 1973 to 1987. Age and sex distributions varied by histologic type. Greater than 98% of pancreatic and biliary cancers were carcinomas, and adenocarcinoma (not otherwise specified) was the most common histologic type recorded. In the liver, hepatocellular carcinoma was the most common type, followed by intrahepatic cholangiocarcinoma. The overall 5-year relative survival rates for these cancers were very low: gallbladder, 12.3%; extrahepatic bile duct, 12.7%; liver 3.1%; and pancreas 2.5% (all stages combined, 1978-1986).
Conclusions: This review confirmed that these carcinomas are associated with a very poor outcome; however, survival was influenced by stage of disease and histologic type. In the gallbladder and extrahepatic bile ducts, papillary adenocarcinoma was associated with the best outcome of all histologic types, and in the exocrine pancreas, mucinous cystadenocarcinoma was associated with the best prognosis.
Similar articles
-
Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study.Arch Pathol Lab Med. 2009 Jan;133(1):67-71. doi: 10.5858/133.1.67. Arch Pathol Lab Med. 2009. PMID: 19123739
-
[Gender-specific influencing factors on incidence, risk factors and outcome of carcinoma of the liver, gallbladder, extrahepatic bile duct and pancreas].Zentralbl Chir. 2014 Apr;139(2):184-92. doi: 10.1055/s-0034-1368231. Epub 2014 Apr 28. Zentralbl Chir. 2014. PMID: 24777600 Review. German.
-
Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.Ann Diagn Pathol. 2009 Dec;13(6):378-83. doi: 10.1016/j.anndiagpath.2009.08.002. Ann Diagn Pathol. 2009. PMID: 19917473
-
Descriptive epidemiology of bile duct carcinoma in Osaka.Jpn J Clin Oncol. 2013 Nov;43(11):1150-5. doi: 10.1093/jjco/hyt126. Epub 2013 Sep 7. Jpn J Clin Oncol. 2013. PMID: 24014885
-
[Tumor grading of the hepatobiliary system].Pathologe. 2016 Jul;37(4):299-303. doi: 10.1007/s00292-016-0176-6. Pathologe. 2016. PMID: 27342594 Review. German.
Cited by
-
Cholangiocarcinoma of the Hepatic Hilum (Klatskin Tumor).Curr Treat Options Gastroenterol. 2002 Apr;5(2):87-94. doi: 10.1007/s11938-002-0055-5. Curr Treat Options Gastroenterol. 2002. PMID: 11879588
-
Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.Gut Liver. 2014 Mar;8(2):196-204. doi: 10.5009/gnl.2014.8.2.196. Epub 2013 Nov 5. Gut Liver. 2014. PMID: 24672662 Free PMC article.
-
Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma.Gastrointest Cancer Res. 2008 Sep;2(5):219-24. Gastrointest Cancer Res. 2008. PMID: 19259306 Free PMC article.
-
Synchronous gallbladder and pancreatic cancer associated with pancreaticobiliary maljunction.World J Gastroenterol. 2014 Oct 21;20(39):14500-4. doi: 10.3748/wjg.v20.i39.14500. World J Gastroenterol. 2014. PMID: 25339838 Free PMC article.
-
Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors.Chin Med J (Engl). 2015 Dec 20;128(24):3335-44. doi: 10.4103/0366-6999.171427. Chin Med J (Engl). 2015. PMID: 26668149 Free PMC article.
MeSH terms
LinkOut - more resources
Medical